Google DeepMind launches TxGemma, open AI models to speed up drug discovery, enhance predictions, and support multi-step ...
Gemini 2.5 Pro represents a significant step forward in AI model design, combining raw power with refined reasoning ...
Google has released an AI called 'TxGemma' to help develop new therapeutic drugs. It can identify promising targets and predict the results of clinical trials, and it can also explain the reasons.
This thinking capability was first introduced by Google in its Gemini 2.0 Flash Thinking Experimental AI model, which was ...
The TxGemma models are – as the name suggests – an offshoot of Google's Gemma family of open-source, generative AI (GenAI) ...
AI unit, has placed strict controls over the release of its research papers to maintain its competitive edge in ...
Developing new therapies: The newest of the bots is TxGemma, a collection of language models aimed at helping pharmaceutical companies with drug discovery. Google announced the initiative Tuesday at ...
During a health-focused event in New York on Tuesday, Google announced that it’s developing a collection of “open” AI models for drug discovery called TxGemma. The AI models, which Google ...
Lilly and Novartis have collectively pledged almost $3 billion to their partnerships with Isomorphic signed last year, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results